VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $686M
- YoY, 2025
- −1.8%
- 5-year CAGR
- +9.8%
- 10-year CAGR
- +11.5%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $686M | −1.8% |
| 2024 | $699M | +20.2% |
| 2023 | $581M | +18.3% |
| 2022 | $491M | +11.3% |
| 2021 | $441M | +2.8% |
| 2020 | $430M | +19.1% |
| 2019 | $361M | +10.9% |
| 2018 | $325M | +10.8% |
| 2017 | $293M | +21.9% |
| 2016 | $241M | +4.2% |
| 2015 | $231M | +30.1% |
| 2014 | $178M | +39.5% |
| 2013 | $127M | +11.4% |
| 2012 | $114M | −3.3% |
| 2011 | $118M | +29.7% |
| 2010 | $91M | +5.1% |
| 2009 | $87M | +49.6% |
| 2008 | $58M | — |